; (C) by amending paragraph (4) to read as follows: (4) Meetings At least twice a year, the task force described in paragraph (1) shall have a public meeting to assess progress and obstacles to implementing the objectives of the Action Plan. The task force may discuss and review based on need or concern the following (among other issues): (A) Federal activities to slow the emergence of antimicrobial-resistant bacteria and prevent the spread of resistant infections. Such activities may include optimal use of vaccines and other infection control measures to prevent infections, implementation of health care policies and antimicrobial stewardship programs that improve patient outcomes, regional efforts to control transmission across community and health care settings, and public awareness campaigns. (B) Federal activities to strengthen national One-Health surveillance efforts, which are efforts addressing the interactions between human, animal, and environmental health, to combat antibiotic resistance. One-Health surveillance efforts to combat antibiotic resistance may include enhanced data sharing and coordination of surveillance and laboratory systems across human and animal settings, and enhanced monitoring of sales, usage, resistance, and management practices of antibiotic drugs along the food-production chain. Such surveillance and laboratory systems may include the National Healthcare Safety Network, the Emerging Infections Program, the National Antimicrobial Resistance Monitoring System, the National Animal Health Monitoring System, the National Animal Health Laboratory Network, the Veterinary Laboratory Investigation and Response Network, and the Antibiotic Resistance Laboratory Network. (C) Federal efforts to advance the development and use of rapid and innovative diagnostic tests for identification and characterization of antibiotic-resistant bacteria. Such efforts may include development of new diagnostic tests and expansion of their availability and use to improve treatment, infection control, and